9-Year Serial CMR Monitoring of Cardiac AL Amyloidosis Regression After Teclistamab.
- DOI
- 10.1016/j.jaccas.2026.109553
- Published
- 2026 Aug 27
- Container
- JACC. Case reports
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaccas.2026.109553,
title = {9-Year Serial CMR Monitoring of Cardiac AL Amyloidosis Regression After Teclistamab.},
author = {Silvestri V and Toledano M and Hivert B and Bourgeois E and Carpentier B and Giraud J and Willaume A and Delelis F and Pascal L},
year = {2026},
journal = {JACC. Case reports},
doi = {10.1016/j.jaccas.2026.109553},
url = {https://doi.org/10.1016/j.jaccas.2026.109553}
}RIS
TY - JOUR TI - 9-Year Serial CMR Monitoring of Cardiac AL Amyloidosis Regression After Teclistamab. AU - Silvestri V AU - Toledano M AU - Hivert B AU - Bourgeois E AU - Carpentier B AU - Giraud J AU - Willaume A AU - Delelis F AU - Pascal L PY - 2026 JO - JACC. Case reports DO - 10.1016/j.jaccas.2026.109553 UR - https://doi.org/10.1016/j.jaccas.2026.109553 ER -
APA
V, S., M, T., B, H., E, B., B, C., J, G., A, W., F, D., & L, P. (2026). 9-Year Serial CMR Monitoring of Cardiac AL Amyloidosis Regression After Teclistamab.. JACC. Case reports. https://doi.org/10.1016/j.jaccas.2026.109553
Source records
- pubmed · retrieved 2026-09-26T03:52:24.015Z